Production (Stage)
Medtronic plc
MDT
$89.92
$0.520.58%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
04/25/2025 | 01/24/2025 | 10/25/2024 | 07/26/2024 | 04/26/2024 | |
---|---|---|---|---|---|
Net Income | 61.47% | -2.12% | 39.71% | 31.73% | -44.53% |
Total Depreciation and Amortization | 5.35% | 5.39% | 0.45% | -1.49% | -3.68% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -38.90% | 1,985.71% | -57.71% | -20.43% | 1,138.64% |
Change in Net Operating Assets | -51.30% | -9.41% | 3.11% | -9.96% | 65.59% |
Cash from Operations | -8.97% | 3.96% | 44.93% | 12.69% | 12.89% |
Capital Expenditure | -7.75% | -37.57% | 12.36% | -46.89% | -12.70% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | 100.00% | -88.46% | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 76.69% | 12.94% | 0.00% | 241.08% | -37.11% |
Cash from Investing | 29.60% | -19.24% | 18.63% | 51.95% | -46.53% |
Total Debt Issued | -100.00% | 100.00% | -100.00% | 541.80% | -95.35% |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | 38.46% | 194.74% | 98.61% | 15.58% | -21.21% |
Repurchase of Common Stock | 83.17% | -37.12% | -27.43% | -1,539.47% | -1,578.35% |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | 1.75% | 2.18% | 2.29% | 2.18% | -0.88% |
Other Financing Activities | -782.93% | 181.22% | -130.43% | -87.50% | 130.83% |
Cash from Financing | 43.07% | -16.87% | -493.33% | -45.91% | 51.76% |
Foreign Exchange rate Adjustments | 571.67% | -395.45% | 102.29% | 179.49% | 18.92% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 388.50% | -149.36% | 396.43% | 113.24% | 88.62% |